Association of CD80 and CD86 expression levels with disease status of Visna/Maedi virus infected sheep

Viral Immunology

Volumn 20, Issue 4, 2007, Pages 609-622

  Reina, Ramsés ^a   Glaria, Idoia ^a   Benavides, Julio ^b   De Andrés, Ximena ^a   Crespo, Helena ^a   Solano, Cristina ^a   Pérez, Valentín ^b   Luján, Lluís ^c   Pérez, Marta M ^c   De La Lastra, José M Pérez ^d   Rosati, Sergio ^e   Blacklaws, Barbara ^f   Harkiss, Gordon ^g   De Andrés, Damián ^a   Amorena, Beatriz ^a,h  

^a CSIC   (Spain)

^b UNIVERSITY OF LEÓN   (Spain)

^c UNIVERSIDAD DE ZARAGOZA   (Spain)

^d INSTITUTO DE INVESTIGACIÓN EN RECURSOS CINEGÉTICOS IREC CSIC UCLM JCCM   (Spain)

^e UNIVERSITY OF TURIN   (Italy)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

^h PUBLIC UNIVERSITY OF NAVARRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; PROTEIN P14; PROTEIN P17; PROTEIN P25; VIRUS ANTIGEN; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; BOVIDS; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; INTERFERON PRODUCTION; LENTIVIRINAE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHEEP; VIRUS INFECTION; VISNA VIRUS;

ANIMALS; ANTIGENS, CD80; ANTIGENS, CD86; GENE PRODUCTS, GAG; GREAT BRITAIN; INTERFERON TYPE II; INTERLEUKIN-2; LENTIVIRUS INFECTIONS; LEUKOCYTES, MONONUCLEAR; RECOMBINANT PROTEINS; SHEEP; SHEEP DISEASES; UP-REGULATION; VIRAL LOAD; VISNA-MAEDI VIRUS;

ANIMALIA; LENTIVIRUS; OVIS ARIES; SMALL RUMINANT LENTIVIRUS; VISNA/MAEDI VIRUS;

EID: 37549072194     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2007.0071     Document Type: Article

References (63)

1. Sabbaj S, Para MF, Fass RJ, Adams PW, Orosz CG, and Whitacre CC: Quantitation of antigen-specific immune responses in human immunodeficiency virus (HIV)-infected individuals by limiting dilution analysis. J Clin Immunol 1992;12:216-224.
2. Foley P, Kazazi F, Biti R, Sorrell TC, and Cunningham AL: HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids. Immunology 1992;75:391-397.
3. Ruegg CL, and Engleman EG: Impaired immunity in AIDS. The mechanisms responsible and their potential reversal by antiviral therapy. Ann N Y Acad Sci 1990; 616:307-317.
4. Teeuwsen VJ, Siebelink KH, de Wolf F, Goudsmit J, UytdeHaag FG, and Osterhaus AD: Impairment of in vitro immune responses occurs within 3 months after HIV-1 seroconversion. AIDS 1990;4:77-81.
5. Schwartz RH: Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992;71:1065-1068.
6. Krummel MF, and Allison JP: CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 1996;183:2533-2540.
7. Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, and Ledbetter JA: Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 1991;173:721-730.
8. Azuma M, Cayabyab M, Phillips JH, and Lanier LL: Requirements for CD28-dependent T cell-mediated cytotoxicity. J Immunol 1993;150:2091-2101.
9. Freeman GJ, Borriello F, Hodes RJ, et al.: Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J Exp Med 1993;178:2185-2192.
10. Schultze J, Nadler LM, and Gribben JG: B7-mediated costimulation and the immune response. Blood Rev 1996;10: 111-127.
11. Bull ME, Vahlenkamp TW, Dow JL, et al.: Spontaneous T cell apoptosis in feline immunodeficiency virus (FIV)-infected cats is inhibited by IL2 and anti-B7.1 antibodies. Vet Immunol Immunopathol 2004;99:25-37.
12. Liegler TJ, and Stites DP: HIV-1 gp120 and anti-gp120 induce reversible unresponsiveness in peripheral CD4 T lymphocytes. J Acquir Immune Defic Syndr 1994;7:340-348.
13. Harding FA, McArthur JG, Gross JA, Raulet DH, and Allison JP: CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992;356:607-609.
14. June CH, Ledbetter JA, Gillespie MM, Lindsten T, and Thompson CB: T-cell proliferation involving the CD28 pathway is associated with cyclosporine- resistant interleukin 2 gene expression. Mol Cell Biol 1987;7:4472-4481.
15. Koulova L, Clark EA, Shu G, and Dupont B: The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells. J Exp Med 1991;173:759-762.
16. Bonnevier JL, and Mueller DL: Cutting edge: B7/CD28 interactions regulate cell cycle progression independent of the strength of TCR signaling. J Immunol 2002;169:6659-6663.
17. Legendre C, Raphael M, Gras G, et al.: CD80 expression is decreased in hyperplastic lymph nodes of HIV+ patients. Int Immunol 1998;10:1847-1851.
18. Wyss-Coray T, Mauri-Hellweg D, Baumann K, Bettens F, Grunow R, and Pichler WJ: The B7 adhesion molecule is expressed on activated human T cells: functional involvement in T-T cell interactions. Eur J Immunol 1993;23:2175-2180.
19. Sansom DM, and Hall ND: B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro. Eur J Immunol 1993;23:295-298.
20. Bird P, Reyburn HT, Blacklaws BA, et al.: The restricted IgG1 antibody response to Maedi Visna virus is seen following infection but not following immunization with recombinant gag protein. Clin Exp Immunol 1995;102:274-280.
21. Torsteinsdottir S, Georgsson G, Gisladottir E, Rafnar B, Palsson PA, and Petursson G: Pathogenesis of central nervous system lesions in Visna: cell-mediated immunity and lymphocyte subsets in blood, brain and cerebrospinal fluid. J Neuroimmunol 1992;41:149-158.
22. Pyrah IT, and Watt NJ: Immunohistological study of the cutaneous delayed type hypersensitivity reaction in sheep. Vet Immunol Immunopathol 1995;48:299-312.
23. Perry LL, Wilkerson MJ, Hullinger GA, and Cheevers WP: Depressed CD4+ T lymphocyte proliferative response and enhanced antibody response to viral antigen in chronic lentivirus-induced arthritis. J Infect Dis 1995;171:328-334.
24. Singh I, McConnell I, and Blacklaws B: Immune response to individual Maedi-Visna virus gag antigens. J Virol 2006; 80:912-919.
25. Terzo EA, Alzueta M, Amorena B, de Andres DF, and de la Lastra JM: Molecular cloning and mRNA tissue-expression of two isoforms of the ovine costimulatory molecule CD80 (B7-1). Vet Immunol Immunopathol 2005;103: 9-19.
26. Terzo EA, de Villarreal MP, Mick V, et al.: Molecular cloning of multiple forms of the ovine B7-2 (CD86) costimulatory molecule. Vet Immunol Immunopathol 2006;114:149-158.
27. Miroux B, and Walker JE: Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels. J Mol Biol 1996;260:289-298.
28. Boarino A, Scalone A, Gradoni L, et al.: Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol 2005;12:647-653.
29. Reyburn HT, Roy DJ, Blacklaws BA, Sargan DR, and McConnell I: Expression of Maedi-Visna virus major core protein, p25: development of a sensitive p25 antigen detection assay. J Virol Methods 1992;37:305-320.
30. Reyburn HT, Roy DJ, Blacklaws BA, Sargan DR, Watt NJ, and McConnell I: Characteristics of the T cell-mediated immune response to maedi-visna virus. Virology 1992;191: 1009-1012.
31. Corpa JM, Perez V, Sanchez MA, and Marin JF: Control of paratuberculosis (Johne's disease) in goats by vaccination of adult animals. Vet Rec 2000;146:195-196.
32. Garcia Marin JF, Tellechea J, Gutiérrez M, Corpa JM, and Pérez V: Evaluation of two vaccines (killed and attenuated) against small ruminant paratuberculosis. In: 7th International Colloquium on Paratuberculosis. (Manning E, Collins MT, eds.). Melbourne, Australia, 1999.
33. Pyrah IT, and Watt NJ: Immunohistological study of the depressed cutaneous DTH response in sheep naturally infected with an ovine lentivirus (Maedi-Visna virus). Clin Exp Immunol 1996;104:32-36.
34. Katzenstein DA, Kundu S, Spritzler J, et al.: Delayed-type hypersensitivity to recombinant HIV envelope glycoprotein (rgp160) after immunization with homologous antigen. J Acquir Immune Defic Syndr 1999;22:341-347.
35. Greenwald RJ, Freeman GJ, and Sharpe AH: The B7 family revisited. Annu Rev Immunol 2005;23:515-548.
36. Cheevers WP, Beyer JC, and Knowles DP: Type 1 and type 2 cytokine gene expression by viral gp135 surface protein-activated T lymphocytes in caprine arthritis-encephalitis lentivirus infection. J Virol 1997;71:6259-6563.
37. Kuchroo VK, Das MP, Brown JA, et al.: B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995;80:707-718.
38. Freeman GJ, Boussiotis VA, Anumanthan A, et al.: B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 1995;2:523-532.
39. Wilkerson MJ, Davis WC, Baszler TV, and Cheevers WP: Immunopathology of chronic lentivirus-induced arthritis. Am J Pathol 1995;146:1433-1443.
40. Bostik P, Mayne AE, Villinger F, Greenberg KP, Powell JD, and Ansari AA: Relative resistance in the development of T cell anergy in CD4+ T cells from simian immunodeficiency virus disease-resistant sooty mangabeys. J Immunol 2001;166:506-516.
41. Clerici M, and Shearer GM: A TH1 → TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-111.
42. Pedersen C, Lindhardt BO, Jensen BL, et al.: Clinical course of primary HIV infection: consequences for subsequent course of infection. BMJ 1989;299:154-157.
43. Jolly PE, Gangopadhyay A, Chen SD, Reddy PG, Weiss HL, and Sapp WJ: Changes in the leukocyte phenotype profile of goats infected with the caprine arthritis encephalitis virus. Vet Immunol Immunopathol 1997;56:97-106.
44. Peterson K, Koets A, Rutten VPMG, Colenbranden B, and Houwers DJ: Flowcytometric assessment of circulating peripheral blood monocytes in small ruminants. Small Rumin Res 2006;65:136-141.
45. Corpa JM, Perez V, and Garcia Marin JF: Differences in the immune responses in lambs and kids vaccinated against paratuberculosis, according to the age of vaccination. Vet Microbiol 2000;77:475-485.
46. Brodie SJ, Bickle HM, and DeMartini JC: Virological markers in cerebrospinal fluid are predictive of ovine lentivirus-associated subclinical encephalomyelitis. Clin Immunol Immunopathol 1995;77:14-18.
47. Zhang Z, Watt NJ, Hopkins J, Harkiss G, and Woodall CJ: Quantitative analysis of maedi-visna virus DNA load in peripheral blood monocytes and alveolar macrophages. J Virol Methods 2000;86:13-20.
48. Narayan O, and Clements JE: Biology and pathogenesis of lentiviruses. J Gen Virol 1989;70:1617-1639.
49. Gendelman HE, Narayan O, Molineaux S, Clements JE, and Ghotbi Z: Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow. Proc Natl Acad Sci U S A 1985;82:7086-7090.
50. Ravazzolo AP, Nenci C, Vogt HR, et al.: Viral load, organ distribution, histopathological lesions, and cytokine mRNA expression in goats infected with a molecular clone of the caprine arthritis encephalitis virus. Virology 2006;350:116-127.
51. Bolea R, Monleon E, Carrasco L, et al.: Maedi-visna virus infection of ovine mammary epithelial cells. Vet Res 2006;37:133-144.
52. Lamara A, Fieni F, Mselli-Lakhal L, Tainturier D, and Chebloune Y: Epithelial cells from goat oviduct are highly permissive for productive infection with caprine arthritis-encephalitis virus (CAEV). Virus Res 2002;87:69-77.
53. Dudhane A, Conti B, Orlikowsky T, et al.: Monocytes in HIV type 1-infected individuals lose expression of costimulatory B7 molecules and acquire cytotoxic activity. AIDS Res Hum Retroviruses 1996;12:885-892.
54. Bhatia S, Edidin M, Almo SC, and Nathenson SG; Different cell surface oligomeric states of B7-1 and B7-2: implications for signaling. Proc Natl Acad Sci U S A 2005;102:15569-15574.
55. Thompson CB, Lindsten T, Ledbetter JA, et al.: CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc Natl Acad Sci U S A 1989;86:1333-1337.
56. Mascarenhas RE, Brodskyn C, Barbosa G, et al.: Peripheral blood mononuclear cells from individuals infected with human T-cell lymphotropic virus type 1 have a reduced capacity to respond to recall antigens. Clin Vaccine Immunol 2006;13:547-552.
57. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, and Sharpe AH: Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995;3:541-547.
58. Walunas TL, Lenschow DJ, Bakker CY, et al.: CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994;1:405-413.
59. Waterhouse P, Penninger JM, Timms E, et al.: Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995;270:985-988.
60. Pentcheva-Hoang T, Egen JG, Wojnoonski K, and Allison JP: B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity 2004;21:401-413.
61. Egen JG, and Allison JP: Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 2002;16:23-35.
62. Giguere JF, Diou J, Madrenas J, and Tremblay MJ: Virus attachment and replication are promoted after acquisition of host CD28 and CD152 by HIV-1. J Infect Dis 2005;192:1265-1268.
63. Martin G, Roy J, Barat C, Ouellet M, Gilbert C, and Tremblay MJ: Human immunodeficiency virus type 1-associated CD40 ligand transactivates B lymphocytes and promotes infection of CD4(+) T cells. J Virol 2007;81: 5872-5881.